Eton Pharma Acquires Galzin, FDA-Approved Treatmen...
Category : Approval/Launch 7 January 2025Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercial...
Approval Launch
Capricor Seeks FDA Approval for Deramiocel to Trea...
Category : Approval/Launch 6 January 2025Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based ther...
SciSparc Gets Renewal for Autism Clinical Trial by...
Category : Approval/Launch 3 January 2025SciSparc Ltd. a specialty clinical-stage pharmaceutical company focusing on the development of thera...
Axsome Posts Mixed Phase III Data in Alzheimer’s A...
Category : Approval/Launch 3 January 2025With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a...
Argenx Gains Japan Approval for VYVDURA in CIDP Tr...
Category : Approval/Launch 30 December 2024Argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the live...
Latest Newsletter Post
-
Imugene Doses First Australian Pati..
7 January 2025
-
Eton Pharma Acquires Galzin, FDA-Ap..
7 January 2025
-
Chime Biologics & Mabgeek Advance M..
7 January 2025
-
Major Breakthrough Achieved in 'Sma..
6 January 2025
-
Neumora's Phase 3 KOASTAL-1 Study o..
6 January 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com